Blaschko’s Lines Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 66 pages | ID: BBC89050CA38EN
Market Monitor Global

Abstracts

Blaschko's lines are the growth lines of the skin (Blaschko's line), which are the growth lines of the skin (Blaschko's line). Under normal circumstances, the lines that extend the human body cannot be seen, which leads to the appearance of the reverse glyph Lesions, in the appearance of the shape and shape of the lesions, there will be no strip-shaped lesions of various shapes, the head is a strip-shaped lesion, and it is a lesion of various shapes.

This report contains market size and forecasts of Blaschko’s Lines Treatment in Global, including the following market information:

Global Blaschko’s Lines Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Blaschko’s Lines Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Topical Retinoid Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Blaschko’s Lines Treatment include GlaxoSmithKline, Novartis AG, Sanofi, Johnson & Johnson, Endo International, Purdue Pharma, Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories and Hisamitsu Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Blaschko’s Lines Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Blaschko’s Lines Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Blaschko’s Lines Treatment Market Segment Percentages, by Type, 2021 (%)

• Topical Retinoid
• Topical Steroid
• Others

Global Blaschko’s Lines Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Blaschko’s Lines Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Homecare
• Specialty Clinics

Global Blaschko’s Lines Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Blaschko’s Lines Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Blaschko’s Lines Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Blaschko’s Lines Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline
• Novartis AG
• Sanofi
• Johnson & Johnson
• Endo International
• Purdue Pharma
• Boehringer Ingelheim International GmbH
• Dr. Reddy's Laboratories
• Hisamitsu Pharmaceutical
• Bristol-Myers Squibb Company
• Mylan N.V.
• Bayer AG

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Blaschko’s Lines Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Blaschko’s Lines Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BLASCHKO’S LINES TREATMENT OVERALL MARKET SIZE

2.1 Global Blaschko’s Lines Treatment Market Size: 2021 VS 2028
2.2 Global Blaschko’s Lines Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Blaschko’s Lines Treatment Players in Global Market
3.2 Top Global Blaschko’s Lines Treatment Companies Ranked by Revenue
3.3 Global Blaschko’s Lines Treatment Revenue by Companies
3.4 Top 3 and Top 5 Blaschko’s Lines Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Blaschko’s Lines Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Blaschko’s Lines Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Blaschko’s Lines Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Blaschko’s Lines Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Blaschko’s Lines Treatment Market Size Markets, 2021 & 2028
  4.1.2 Topical Retinoid
  4.1.3 Topical Steroid
  4.1.4 Others
4.2 By Type - Global Blaschko’s Lines Treatment Revenue & Forecasts
  4.2.1 By Type - Global Blaschko’s Lines Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Blaschko’s Lines Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Blaschko’s Lines Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Blaschko’s Lines Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Homecare
  5.1.4 Specialty Clinics
5.2 By Application - Global Blaschko’s Lines Treatment Revenue & Forecasts
  5.2.1 By Application - Global Blaschko’s Lines Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Blaschko’s Lines Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Blaschko’s Lines Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Blaschko’s Lines Treatment Market Size, 2021 & 2028
6.2 By Region - Global Blaschko’s Lines Treatment Revenue & Forecasts
  6.2.1 By Region - Global Blaschko’s Lines Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Blaschko’s Lines Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Blaschko’s Lines Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Blaschko’s Lines Treatment Revenue, 2017-2028
  6.3.2 US Blaschko’s Lines Treatment Market Size, 2017-2028
  6.3.3 Canada Blaschko’s Lines Treatment Market Size, 2017-2028
  6.3.4 Mexico Blaschko’s Lines Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Blaschko’s Lines Treatment Revenue, 2017-2028
  6.4.2 Germany Blaschko’s Lines Treatment Market Size, 2017-2028
  6.4.3 France Blaschko’s Lines Treatment Market Size, 2017-2028
  6.4.4 U.K. Blaschko’s Lines Treatment Market Size, 2017-2028
  6.4.5 Italy Blaschko’s Lines Treatment Market Size, 2017-2028
  6.4.6 Russia Blaschko’s Lines Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Blaschko’s Lines Treatment Market Size, 2017-2028
  6.4.8 Benelux Blaschko’s Lines Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Blaschko’s Lines Treatment Revenue, 2017-2028
  6.5.2 China Blaschko’s Lines Treatment Market Size, 2017-2028
  6.5.3 Japan Blaschko’s Lines Treatment Market Size, 2017-2028
  6.5.4 South Korea Blaschko’s Lines Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Blaschko’s Lines Treatment Market Size, 2017-2028
  6.5.6 India Blaschko’s Lines Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Blaschko’s Lines Treatment Revenue, 2017-2028
  6.6.2 Brazil Blaschko’s Lines Treatment Market Size, 2017-2028
  6.6.3 Argentina Blaschko’s Lines Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Blaschko’s Lines Treatment Revenue, 2017-2028
  6.7.2 Turkey Blaschko’s Lines Treatment Market Size, 2017-2028
  6.7.3 Israel Blaschko’s Lines Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Blaschko’s Lines Treatment Market Size, 2017-2028
  6.7.5 UAE Blaschko’s Lines Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GlaxoSmithKline
  7.1.1 GlaxoSmithKline Corporate Summary
  7.1.2 GlaxoSmithKline Business Overview
  7.1.3 GlaxoSmithKline Blaschko’s Lines Treatment Major Product Offerings
  7.1.4 GlaxoSmithKline Blaschko’s Lines Treatment Revenue in Global Market (2017-2022)
  7.1.5 GlaxoSmithKline Key News
7.2 Novartis AG
  7.2.1 Novartis AG Corporate Summary
  7.2.2 Novartis AG Business Overview
  7.2.3 Novartis AG Blaschko’s Lines Treatment Major Product Offerings
  7.2.4 Novartis AG Blaschko’s Lines Treatment Revenue in Global Market (2017-2022)
  7.2.5 Novartis AG Key News
7.3 Sanofi
  7.3.1 Sanofi Corporate Summary
  7.3.2 Sanofi Business Overview
  7.3.3 Sanofi Blaschko’s Lines Treatment Major Product Offerings
  7.3.4 Sanofi Blaschko’s Lines Treatment Revenue in Global Market (2017-2022)
  7.3.5 Sanofi Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Blaschko’s Lines Treatment Major Product Offerings
  7.4.4 Johnson & Johnson Blaschko’s Lines Treatment Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 Endo International
  7.5.1 Endo International Corporate Summary
  7.5.2 Endo International Business Overview
  7.5.3 Endo International Blaschko’s Lines Treatment Major Product Offerings
  7.5.4 Endo International Blaschko’s Lines Treatment Revenue in Global Market (2017-2022)
  7.5.5 Endo International Key News
7.6 Purdue Pharma
  7.6.1 Purdue Pharma Corporate Summary
  7.6.2 Purdue Pharma Business Overview
  7.6.3 Purdue Pharma Blaschko’s Lines Treatment Major Product Offerings
  7.6.4 Purdue Pharma Blaschko’s Lines Treatment Revenue in Global Market (2017-2022)
  7.6.5 Purdue Pharma Key News
7.7 Boehringer Ingelheim International GmbH
  7.7.1 Boehringer Ingelheim International GmbH Corporate Summary
  7.7.2 Boehringer Ingelheim International GmbH Business Overview
  7.7.3 Boehringer Ingelheim International GmbH Blaschko’s Lines Treatment Major Product Offerings
  7.7.4 Boehringer Ingelheim International GmbH Blaschko’s Lines Treatment Revenue in Global Market (2017-2022)
  7.7.5 Boehringer Ingelheim International GmbH Key News
7.8 Dr. Reddy's Laboratories
  7.8.1 Dr. Reddy's Laboratories Corporate Summary
  7.8.2 Dr. Reddy's Laboratories Business Overview
  7.8.3 Dr. Reddy's Laboratories Blaschko’s Lines Treatment Major Product Offerings
  7.8.4 Dr. Reddy's Laboratories Blaschko’s Lines Treatment Revenue in Global Market (2017-2022)
  7.8.5 Dr. Reddy's Laboratories Key News
7.9 Hisamitsu Pharmaceutical
  7.9.1 Hisamitsu Pharmaceutical Corporate Summary
  7.9.2 Hisamitsu Pharmaceutical Business Overview
  7.9.3 Hisamitsu Pharmaceutical Blaschko’s Lines Treatment Major Product Offerings
  7.9.4 Hisamitsu Pharmaceutical Blaschko’s Lines Treatment Revenue in Global Market (2017-2022)
  7.9.5 Hisamitsu Pharmaceutical Key News
7.10 Bristol-Myers Squibb Company
  7.10.1 Bristol-Myers Squibb Company Corporate Summary
  7.10.2 Bristol-Myers Squibb Company Business Overview
  7.10.3 Bristol-Myers Squibb Company Blaschko’s Lines Treatment Major Product Offerings
  7.10.4 Bristol-Myers Squibb Company Blaschko’s Lines Treatment Revenue in Global Market (2017-2022)
  7.10.5 Bristol-Myers Squibb Company Key News
7.11 Mylan N.V.
  7.11.1 Mylan N.V. Corporate Summary
  7.11.2 Mylan N.V. Business Overview
  7.11.3 Mylan N.V. Blaschko’s Lines Treatment Major Product Offerings
  7.11.4 Mylan N.V. Blaschko’s Lines Treatment Revenue in Global Market (2017-2022)
  7.11.5 Mylan N.V. Key News
7.12 Bayer AG
  7.12.1 Bayer AG Corporate Summary
  7.12.2 Bayer AG Business Overview
  7.12.3 Bayer AG Blaschko’s Lines Treatment Major Product Offerings
  7.12.4 Bayer AG Blaschko’s Lines Treatment Revenue in Global Market (2017-2022)
  7.12.5 Bayer AG Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Blaschko’s Lines Treatment Market Opportunities & Trends in Global Market
Table 2. Blaschko’s Lines Treatment Market Drivers in Global Market
Table 3. Blaschko’s Lines Treatment Market Restraints in Global Market
Table 4. Key Players of Blaschko’s Lines Treatment in Global Market
Table 5. Top Blaschko’s Lines Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Blaschko’s Lines Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Blaschko’s Lines Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Blaschko’s Lines Treatment Product Type
Table 9. List of Global Tier 1 Blaschko’s Lines Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Blaschko’s Lines Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Blaschko’s Lines Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Blaschko’s Lines Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Blaschko’s Lines Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Blaschko’s Lines Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Blaschko’s Lines Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Blaschko’s Lines Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Blaschko’s Lines Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Blaschko’s Lines Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Blaschko’s Lines Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Blaschko’s Lines Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Blaschko’s Lines Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Blaschko’s Lines Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Blaschko’s Lines Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Blaschko’s Lines Treatment Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Blaschko’s Lines Treatment Product Offerings
Table 32. GlaxoSmithKline Blaschko’s Lines Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Novartis AG Corporate Summary
Table 34. Novartis AG Blaschko’s Lines Treatment Product Offerings
Table 35. Novartis AG Blaschko’s Lines Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Blaschko’s Lines Treatment Product Offerings
Table 38. Sanofi Blaschko’s Lines Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Blaschko’s Lines Treatment Product Offerings
Table 41. Johnson & Johnson Blaschko’s Lines Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Endo International Corporate Summary
Table 43. Endo International Blaschko’s Lines Treatment Product Offerings
Table 44. Endo International Blaschko’s Lines Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Purdue Pharma Corporate Summary
Table 46. Purdue Pharma Blaschko’s Lines Treatment Product Offerings
Table 47. Purdue Pharma Blaschko’s Lines Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Boehringer Ingelheim International GmbH Corporate Summary
Table 49. Boehringer Ingelheim International GmbH Blaschko’s Lines Treatment Product Offerings
Table 50. Boehringer Ingelheim International GmbH Blaschko’s Lines Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Dr. Reddy's Laboratories Corporate Summary
Table 52. Dr. Reddy's Laboratories Blaschko’s Lines Treatment Product Offerings
Table 53. Dr. Reddy's Laboratories Blaschko’s Lines Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Hisamitsu Pharmaceutical Corporate Summary
Table 55. Hisamitsu Pharmaceutical Blaschko’s Lines Treatment Product Offerings
Table 56. Hisamitsu Pharmaceutical Blaschko’s Lines Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Bristol-Myers Squibb Company Corporate Summary
Table 58. Bristol-Myers Squibb Company Blaschko’s Lines Treatment Product Offerings
Table 59. Bristol-Myers Squibb Company Blaschko’s Lines Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Mylan N.V. Corporate Summary
Table 61. Mylan N.V. Blaschko’s Lines Treatment Product Offerings
Table 62. Mylan N.V. Blaschko’s Lines Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Bayer AG Corporate Summary
Table 64. Bayer AG Blaschko’s Lines Treatment Product Offerings
Table 65. Bayer AG Blaschko’s Lines Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Blaschko’s Lines Treatment Segment by Type in 2021
Figure 2. Blaschko’s Lines Treatment Segment by Application in 2021
Figure 3. Global Blaschko’s Lines Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Blaschko’s Lines Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Blaschko’s Lines Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Blaschko’s Lines Treatment Revenue in 2021
Figure 8. By Type - Global Blaschko’s Lines Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Blaschko’s Lines Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Blaschko’s Lines Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Blaschko’s Lines Treatment Revenue Market Share, 2017-2028
Figure 12. US Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Blaschko’s Lines Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Blaschko’s Lines Treatment Revenue Market Share, 2017-2028
Figure 24. China Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Blaschko’s Lines Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Blaschko’s Lines Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Blaschko’s Lines Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Blaschko’s Lines Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis AG Blaschko’s Lines Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Blaschko’s Lines Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Blaschko’s Lines Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Endo International Blaschko’s Lines Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Purdue Pharma Blaschko’s Lines Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Boehringer Ingelheim International GmbH Blaschko’s Lines Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Dr. Reddy's Laboratories Blaschko’s Lines Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Hisamitsu Pharmaceutical Blaschko’s Lines Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Bristol-Myers Squibb Company Blaschko’s Lines Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Mylan N.V. Blaschko’s Lines Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Bayer AG Blaschko’s Lines Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)